Angiodynamics (ANGO) Net Cash Flow Growth (1y) (2011 - 2026)
Angiodynamics (ANGO) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -342.50% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 131.47% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -47.85% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -40.20% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -194.15% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 102.38% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 84.02% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 144.81% |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn | 56.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 56.57% |
| Nov 30, 2025 | 582.49% |
| Aug 31, 2025 | 18.17% |
| May 31, 2025 | 546.17% |
| Feb 28, 2025 | -152.36% |
| Nov 30, 2024 | -119.58% |
| Aug 31, 2024 | -263.41% |
| May 31, 2024 | -116.19% |
| Feb 29, 2024 | 10,549.70% |
| Nov 30, 2023 | -38.88% |
| Aug 31, 2023 | 428.34% |
| May 31, 2023 | 181.98% |
| Feb 28, 2023 | 101.58% |
| Nov 30, 2022 | 628.57% |
| Aug 31, 2022 | 68.57% |
| May 31, 2022 | 180.06% |
| Feb 28, 2022 | -194.88% |
| Nov 30, 2021 | -109.59% |
| Aug 31, 2021 | -85.71% |
| May 31, 2021 | -123.37% |